Results 191 to 200 of about 189,690 (343)

Beta-blocker therapy after myocardial infarction with preserved LVEF (≥50%): a systematic review and Bayesian meta-analysis with time-to-event reconstruction. [PDF]

Am Heart J Plus
Al-Shammari AS, Kurmasha YH, Islam MR, Hammadeh BM, Khaleel NI, Hamed BM, Altaii H, Jena N, Gerdes J, Sokos G, Daggubati R, Sattar Y, Refaat M.   +12 more
europepmc   +1 more source

Therapeutic Role of Beta-blockers in Hypertension: A Pragmatic Reappraisal

, 2016
Soumitra Kumar
openalex   +1 more source

Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker. [PDF]

, 1975
M. Elliot, P M Cullen, C I Phillips
openalex   +1 more source

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells

FEBS Open Bio, EarlyView.
KLK7, a tissue kallikrein‐related peptidase, is elevated in advanced colorectal cancer and associated with shorter survival. High KLK7 levels in ascites correlate with peritoneal metastasis. In mice, KLK7 overexpression increases metastasis. In vitro, KLK7 enhances cancer cell proliferation, migration, adhesion, and spheroid formation, driving ...
Yosr Z. Haffani, Tobias Dreyer, Meriem Naim, Rea Lo Dico, Natalia A. Ignatenko, Viktor Magdolen, Dalila Darmoul   +6 more
wiley   +1 more source

Impact of Variability in Blood Pressure and Heart Rate on Beta-Blocker Adherence. [PDF]

J Clin Hypertens (Greenwich)
Li Y, Sun JY, Guo QY, Han HY, Jia DA, Zhou ZM, Wang ZJ, Zhao YX, Zhou YJ, Yang SW.   +9 more
europepmc   +1 more source

EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES

, 2009
Olga Fedorishina, A. A. Dzizinsky, К. В. Протасов, В. А. Протасова, Т. И. Кучерова, Е. Г. Захарова, Д. Д. Басхаева, Т. С. Сухорослова, О. В. Перкова   +8 more
openalex   +2 more sources

Mycobacterial cell division arrest and smooth‐to‐rough envelope transition using CRISPRi‐mediated genetic repression systems

FEBS Open Bio, EarlyView.
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point, Wafaa Achache, Janïs Laudouze, Eliana Sepulveda Ramos, Mickaël Maziero, Céline Crauste, Stéphane Canaan, Pierre Santucci   +7 more
wiley   +1 more source

Impact of digoxin versus beta-blocker in patients with coexistent atrial fibrillation and heart failure: a target trial emulation. [PDF]

BMC Med
Liu L, Cai AP, Huang JY, Gu WL, Guo R, Zhang JN, Xuan HC, Chan YH, Xu AM, Cheung BMY, Lip GYH, Yiu KH.   +11 more
europepmc   +1 more source

Domain associated with zinc fingers‐containing NF90‐NF45 complex inhibits m6A modification of primary microRNA by suppressing METTL3/14 activity

FEBS Open Bio, EarlyView.
NF90–NF45 functions as a negative regulator of methyltransferase‐like 3/14 (METTL3/14)‐mediated N6‐methyladenosine (m6A) modification on primary microRNAs (pri‐miRNAs). NF90–NF45 binds to anti‐oncogenic pri‐miRNAs and inhibits their m6A modification, thereby suppressing the biogenesis of anti‐oncogenic miRNAs.
Takuma Higuchi, Shunsuke Morioka, Keiko Morisawa, Kazutsugu Matsukawa, Shingo Ashida, Takeshi Suzuki, Shuji Sakamoto   +6 more
wiley   +1 more source

Ventricular Fibrillation in Patient with Multi-vessel Coronary Spasm Four Days after the Initiation of Oral Beta-blocker

, 2016
Manabu Kurabayashi, Hidetoshi Suzuki, Tsukasa Shimura, Yasuteru Yamauchi, Kaoru Okishige   +4 more
openalex   +2 more sources